Pleural and retroperitoneal fibrosis from dihydroergotamine.
作者信息
Malaquin F, Urban T, Ostinelli J, Ghedira H, Lacronique J
出版信息
N Engl J Med. 1989 Dec 21;321(25):1760.
PMID:2594034
Abstract
摘要
相似文献
1
Pleural and retroperitoneal fibrosis from dihydroergotamine.二氢麦角胺所致的胸膜和腹膜后纤维化。
N Engl J Med. 1989 Dec 21;321(25):1760.
2
Diagnosis and management of pergolide-induced fibrosis.培高利特诱导的纤维化的诊断与管理。
Mov Disord. 2004 Jun;19(6):699-704. doi: 10.1002/mds.20200.
3
[Retroperitoneal fibrosis and ergot derivatives. Ophthalmological adverse effects].
Bull Soc Ophtalmol Fr. 1974 Mar;74(3):281-6.
4
[A case of retroperitoneal fibrosis following dihydroergotamine therapy, with special reference to partial diabetes insipidus and positive Ga scan].[二氢麦角胺治疗后发生腹膜后纤维化1例，特别涉及部分性尿崩症及镓扫描阳性]
Nihon Naika Gakkai Zasshi. 1984 Jun;73(6):864-70.
5
[Letter: Pleuropulmonary fibrosis due to methysergide with circulating immune complexes[].[信件：麦角酰二乙胺导致的胸膜肺纤维化伴循环免疫复合物[]。
Nouv Presse Med. 1975 Nov 15;4(39):2809.
6
Syndrome of pleural and retrosternal "bridging" fibrosis and retroperitoneal fibrosis in patients with asbestos exposure.石棉暴露患者的胸膜及胸骨后“桥接”纤维化和腹膜后纤维化综合征
Thorax. 2008 Feb;63(2):177-9. doi: 10.1136/thx.200X.081646.
7
Fibrosis due to ergot derivatives: exposure to risk should be weighed up.
Prescrire Int. 2002 Dec;11(62):186-9.
8
[A case of pleural involvement followed by idiopathic retroperitoneal fibrosis].[一例继发自发性腹膜后纤维化的胸膜受累病例]
Nihon Kyobu Shikkan Gakkai Zasshi. 1993 Jul;31(7):876-80.
9
Retroperitoneal fibrosis and haloperidol.腹膜后纤维化与氟哌啶醇
Am J Psychiatry. 1982 Nov;139(11):1524-5.
10
Pergolide-induced retroperitoneal fibrosis.
Int J Clin Pract. 2000 Jul-Aug;54(6):403.
Zotero 插件